18.09.2023
LMU spin-off QuGen GmbH founded!
QuGen GmbH, founded by Thomas carell and Pascal Giehr, provides high-sensitive long read sequencing (PacBio), bisulfite-free sequencing of DNA methylation and mass spectrometry quantification of non-canonical nucleobases in DNA and RNA. This includes also sample preparation and data analysis. With this QuGen fulfills unmet needs in quantification and positional information of epigenetic nucleobases.
Eisbach Bio GmbH unter den 5 deutschen Biotech-Hoffnungen
Eisbach Bio GmbH unter den 5 deutschen Biotech-Hoffnungen
Die LMU Ausgründung Eisbach Bio GmbH wurde...
Eisbach Bio erhält CRPIT Grant zur Förderung neuer Krebsmedikamente
Eisbach Bio GmbH erhält CRPIT Grant zur Förderung neuer Krebsmedikamente
Die LMU Ausgründung Eisbach...
2024 Nobel Prize for microRNA
2024 Nobel Prize awarded to the discovery of microRNA
Victor Ambros and Gary Ruvkun have been awarded...
Reinhart-Koselleck-Grant for Prof. Irmela Jeremias
Reinhart-Koselleck-Grant for Prof. Irmela Jeremias
Prof. Irmela Jeremias is a pediatrician at the...
Proof of Concept Grant for Thomas Carell
The European Research Council has awarded the LMU chemist a grant for the preclinical development of...
Symposium: New Frontier in Chemical Biology
Joint symposium by CNATM, SFB1309 and Center of Advanced Study (CAS): guest speaker Benjamin List (Nobel...
LMU Spin-off RNhale gegründet
The formation of the biotech spinoff RNhale can be traced back to Professor Olivia Merkel's groundbreaking...
Click-Synthese von Zucker-modifizierten Oligonukleotiden
Nucleic acids in the form of siRNA, antisense oligonucleotides or mRNA are currently explored as new...
EpiCure gewinnt 2. Runde beim Businessplanwettbewerb
EpiCure, eine Firmenidee, die auf Ausgründung wartet, gehört mir ihrem Konzept zu den 5 Siegern...
EisbachBio GmbH: Allosterischen Inhibitor erhält FDA-Freigabe
Eisbach Bio GmbH (“Eisbach” or the “Company”), a privately-held clinical-stage biotechnology company...